Yuniarti full story, cancer patients if "victims" BPJS – VIVA



[ad_1]

VIVA – The patient with bad cancer, Yuniarti Tanjung, and his family have the intention to sue the Social Insurance Agency and President Jokowi. They are disappointed because the agency withdraws the medications they should receive as a participant BPJS Health

Husband, Edy Hariadi, said that this incident had started in December 2017. At that time, his wife's family saw no swelling in the neck or lymph nodes. Since his office received a health insurance card for his health insurance in January 2018, his wife went to Puskemas Duren Sawit in East Jakarta, the nearest health center with his home. according to the BPJS procedure. . Then by Puskesmas Duren Sawit, his wife was referred to the Disease Specialist at the Regional General Hospital (RSUD) Budhi Asih, East Jakarta.


"After examination, the hospital doctor Budhi Asih suspected that the tumor was cancerous or in oncology there, and since early February 2018, my wife was referred to the hospital of the # 39, Friendship of Rawamangun, in East Jakarta where my wife was taken in charge by Dr. Budi Harapan Siregar, Sp.B. In a written statement received by VIVA, Monday, July 16, 2018.

By the doctor, he continued, then performed a biopsy, or a swab on his wife's right neck.Slightly a positive cancer result.But according to the laboratory test of Pathology Anatomy (PA) Friendship Hospital is not the main cancer, but the cancer that has metastasis (spread) .Is apparently the main source comes from the chest.
"The conclusion of a biopsy of the neck biopsy: adenocarcinoma metastases that may come from the chest (signed by pathologist Dr. Romi Baginda, Sp.PA)," he said.

Of course, the doctor returned the results to the laboratory. Pain Friendship for further examination with Imuno Histo Chemistry or CPI Controls. Kalgem CPI results achieved: ER +, PR +, Her2 + with overexpressed, category 3 + score, Ki67: expressed, moderate to high intensity of 60% to 70% (highly proliferative).

"In other words my wife said she was suffering from HER2-positive bad cancer that had metastasized or spread. The IPC results were out May 10, 2018." Edy said.

Edy says after surgical removal of the right bad, the results showed that PA meat in his wife's bad contains malignant tumors. The former journalist of Femina magazine was positive for HER2-positive bad cancer, metastasized and was in stage 3 B.

Postoperative, Yuniarti suggested to undergo chemotherapy. On June 24, 2018, doctors also prescribed three chemotherapeutic drugs and one drug clbadified as a target therapy for the treatment of HER2-positive bad cancer, either herceptin or another name for trastuzumab.

Note that trastuzumab is safe, high quality and nutritious. accessibility under the National Health Service under the Decree of the Minister of Health of the Republic of Indonesia on the 2018 national form of 28 December 2017. On page 66 of point 43, the decision explicitly states that the Trastuzumab is administered to patients with metastatic bad cancer. BPJS Health must guarantee the availability of the drug.

According to Edy, trastuzumab has been shown to be effective in prolonging the age of patients with HER2-positive cancer. An example of his life is Aryanthi Baramuli Putri, president of the Cancer Information Support Center (CISC), a patient with HER2 positive bad cancer who has gradually lived 15 years more with trastuzumab or l & # 39; herceptin. Incidentally, my wife and Aryanthi Baramuli have been friends for a long time.

[ad_2]
Source link